{"id":3001,"date":"2019-10-10T00:13:04","date_gmt":"2019-10-09T22:13:04","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=3001"},"modified":"2024-02-22T10:44:24","modified_gmt":"2024-02-22T09:44:24","slug":"infecciones-respiratorias-y-en-el-huesped-inmunocomprometido","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-de-medicina-traslacional\/programa-de-enfermedades-infecciosas-y-trasplantes\/infecciones-respiratorias-y-en-el-huesped-inmunocomprometido\/","title":{"rendered":"Infecciones Respiratorias y en el Hu\u00e9sped Inmunocomprometido"},"content":{"rendered":"\n
Este grupo centra su actividad investigadora en dos grandes \u00e1reas. Por una parte, en las infecciones respiratorias, principalmente la neumon\u00eda de la comunidad y la tuberculosis. Por otra, en las infecciones en el hu\u00e9sped inmunocomprometido, incluyendo los enfermos con c\u00e1ncer, trasplantes de progenitores hematopo\u00e9ticos (m\u00e9dula \u00f3sea) y de \u00f3rgano s\u00f3lido y los pacientes con infecci\u00f3n por VIH – SIDA. Sus l\u00edneas de investigaci\u00f3n se centran en varios aspectos epidemiol\u00f3gicos, cl\u00ednicos, diagn\u00f3sticos, terap\u00e9uticos y preventivos de estas infecciones.<\/p>\n
– Abelenda Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, Rodr\u00edguez Molinero A, Izquierdo E, D\u00edaz Brito V, Sanmart\u00ed M, Padull\u00e9s A, Grau I, Ras M, Bergas A, Guillem L, Blanco Ar\u00e9valo A, Alvarez Pouso C, Pallar\u00e9s N, Videla S, Teb\u00e9 C, Carratal\u00e0 J. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID). Clin. Microbiol. Infect. 2021;27(11):1685-1692. doi:10.1016\/j.cmi.2021.06.041. IF:8,07.<\/p>\n
– Rosas IO, Diaz G, Gottlieb RL, Lobo SM, Robinson P, Hunter BD, Cavalcante AW, Overcash JS, Hanania NA, Skarbnik A, Garcia Diaz J, Gordeev I, Carratala J, Gordon O, Graham E, Lewin Koh N, Tsai L, Tuckwell K, Cao HY, Brainard D, Olsson JK. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021;47(11):1258-1270. doi:10.1007\/s00134-021-06507-x. IF:17,44.<\/p>\n
– Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda Alonso G, Escalera A, Amanat F, Jiang K, Krammer F, Carratala J, Garcia Sastre A. Immunological imprinting of the antibody response in COVID-19 patients. Nat. Commun. 2021;12(1):3781-3781. doi:10.1038\/s41467-021-23977-1. IF:14,92.<\/p>\n
– Gutierrez B, del Toro MD, Borobia AM, Carcas A, Jarrin I, Yllescas M, Ryan P, Pachon J, Carratala J, Berenguer J, Arribas JR, Rodriguez Bano J, REIPI 19 GRP, COVID HULP GRP. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021;21(6):783-792. doi:10.1016\/S1473-3099(21)00019-0. IF:25,07.<\/p>\n
– Gutierrez B, del Toro MD, Borobia AM, Carcas A, Jarrin I, Yllescas M, Ryan P, Pachon J, Carratala J, Berenguer J, Arribas JR, Rodriguez Bano J, REIPI 19 GRP, COVID HULP GRP. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021;21(6):783-792. doi:10.1016\/S1473-3099(21)00019-0. IF:25,07.<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t –\u00a0\u00a0\u00a0\u00a020FIS052. Identificaci\u00f3n del perfil transcrip\u00f3mico din\u00e1mico en pacientes con COVID-19 y s\u00edndrome de distr\u00e9s respiratorio agudo (TRANSCOVID). (COV20\/00121). 2020-2021. IP:CARRATALA FERNANDEZ,JORDI.<\/p>\n –\u00a0\u00a0\u00a0\u00a019MAR001. Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia: a randomized controlled trial. (201808-10). FUNDACI\u00d3 LA MARAT\u00d3 DE TV3. 2019-2022. IP:CARRATALA FERNANDEZ,JORDI.<\/p>\n –\u00a0\u00a0\u00a0\u00a019FIS034. Estudio de las reversiones de una prueba de liberaci\u00f3n de interfer\u00f3n-? (QuantiFERON-TB Gold Plus) para la optimizaci\u00f3n del estudio de contactos de tuberculosis. (PI18\/00423). ISCIII. 2019-2021. IP:SANTIN CEREZALES,MIGUEL.<\/p>\n –\u00a0\u00a0\u00a0\u00a018FIS020. Eficacia de la infusi\u00f3n extendida de los antibi\u00f3ticos \u00df-lact\u00e1micos en el tratamiento de la neutropenia febril en los pacientes hematol\u00f3gicos. (PI17\/01372). ISCIII. 2018-2022. IP:GUDIOL GONZALEZ,CARLOTA.<\/p>\n –\u00a0\u00a0\u00a0\u00a017CEE003. ANTI-SUPERBUG Precommercial procurement. (688878). AQUAS (AG. DE QUALITAT I AVALUACIO S. C); BEDIN SARA; COMISSI\u00d3 EUROPEA; FUND.DOCENCIA I RECERCA MUTUA TERRA; FUNDACIO IDIBELL; HELIOS KLINIKUM WUPPERTAL GMBH; INSTITUT CATALA D’ONCOLOGIA; PROVINCIA AUTONOMA DI TRENTO; RISE ACREO AB; RISE RESEARCH INSTITUTES OF SWEDEN AB; SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST; UNIVERSITAETSKLINIKUM AACHEN. 2017-2022. IP:LIMON CACERES,ENRIQUE.<\/p>\n\t\t\t\t\n Infecciones Respiratorias y en el Hu\u00e9sped Inmunocomprometido Resumen Este grupo centra su actividad investigadora en dos grandes \u00e1reas. Por una parte, en las infecciones respiratorias, principalmente la neumon\u00eda de la comunidad y la tuberculosis. Por otra, en las infecciones en el hu\u00e9sped inmunocomprometido, incluyendo los enfermos con c\u00e1ncer, trasplantes de progenitores hematopo\u00e9ticos (m\u00e9dula \u00f3sea) y […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":581,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-10 23:12:01","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3001"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=3001"}],"version-history":[{"count":7,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3001\/revisions"}],"predecessor-version":[{"id":23902,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3001\/revisions\/23902"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/581"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=3001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\t\tCarratal\u00e0 Fern\u00e1ndez, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjcarratala@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n
\n\t\tCarratal\u00e0 Fern\u00e1ndez, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjcarratala@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSantin Cerezales, Miguel\n\t<\/h4>\n
\n\t\t\n\t\tmsantin@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tGudiol Gonzalez, Carlota\n\t<\/h4>\n
\n\t\t\n\t\tcgudiol@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSabe Fern\u00e1ndez, Nuria\n\t<\/h4>\n
\n\t\t\n\t\tnsabe@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tLimon Caceres, Enrique\n\t<\/h4>\n
\n\t\t\n\t\telimonc@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tImaz Vacas, Arkaitz\n\t<\/h4>\n
\n\t\t\n\t\taimaz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tAlcaide Fernandez de Vega, Fernando\n\t<\/h4>\n
\n\t\t\n\t\tfalcaide@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tOriol Bermudez, Isabel\n\t<\/h4>\n
\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n
\n\t\t\n\t\t@Carlotasway3\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as principales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as cl\u00ednicos\/as\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte de gesti\u00f3n\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn metaan\u00e1lisis del IDIBELL y el Hospital de Bellvitge examina el uso de antibi\u00f3ticos beta-lact\u00e1micos en la neutropenia febril<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa monoterapia podr\u00eda reemplazar la terapia combinada en la endocarditis<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t11\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDesarrollan un modelo que predice la evoluci\u00f3n cl\u00ednica de los pacientes con COVID-19 cuando realizan el ingreso hospitalario<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/12\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn estudio identifica factores de riesgo de padecer COVID-19 grave en pacientes con VIH<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t26\/10\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa huella inmunol\u00f3gica condiciona la respuesta al SARS-CoV-2<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t28\/07\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting sobre los Proyectos de Investigaci\u00f3n en Salud concedidos por el ISCIII<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tJordi Carratal\u00e0 y Fernando Fern\u00e1ndez Aranda, nuevos catedr\u00e1ticos de la Universidad de Barcelona<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t04\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEdad y sexo masculino, factores clave en el riesgo de mortalidad de ingreso hospitalario por la COVID-19<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/08\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tSalud financiar\u00e1 3 proyectos del IDIBELL sobre la Covid-19<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t08\/04\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa nueva gu\u00eda cl\u00ednica de la IDSA \/ ATS recomienda menos antibi\u00f3ticos para tratar la neumon\u00eda intrahospitalaria y la asociada a ventilaci\u00f3n mec\u00e1nica<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/07\/2016\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"